BioAtla (BCAB) Non Operating Income (2021 - 2024)

BioAtla's (BCAB) quarterly Non Operating Income came in at -$1000.0 in Q4 2024, up 96.3% year-on-year from -$509.43 in Q1 2024, and up 87.5% quarter-over-quarter from -$8000.0 in Q3 2024.

BioAtla (BCAB) Non Operating Income (2021 - 2024) Analysis & Trends

BioAtla's Non Operating Income history runs 4 years deep, the most recent figure standing at -$1000.0 for Q4 2024.

  • On a quarterly basis, Non Operating Income rose 96.3% year-over-year to -$1000.0 in Q4 2024; TTM through Dec 2024 was -$9000.0, a 89.66% increase from a year earlier, with the FY2025 full-year figure at -$1.0 million, down 11388.89% from the prior year.
  • Non Operating Income climbed to -$1000.0 in Q4 2024 per BCAB's latest filing, from -$8000.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $30000.0 in Q3 2022 and bottomed at -$39000.0 in Q3 2023.
  • The 4-year median for Non Operating Income is -$4500.0 (2021), against an average of -$7083.3.
  • Biggest YoY gain for Non Operating Income was 3100.0% in 2022; the steepest drop was 1600.0% in 2022.
  • Year by year, Non Operating Income stood at $2000.0 in 2021, then plunged by 1600.0% to -$30000.0 in 2022, then grew by 10.0% to -$27000.0 in 2023, then surged by 96.3% to -$1000.0 in 2024.
  • Per Business Quant, the three latest BCAB Non Operating Income figures stand at -$1000.0 (Q4 2024), -$8000.0 (Q3 2024), and -$27000.0 (Q4 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -9.22 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 188.30 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - 5.75 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -8.59 Mn
10 BioAtla 5.74 Mn 5.74 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 -1,000.00
Sep 30, 2024 -8,000.00
Dec 31, 2023 -27,000.00
Sep 30, 2023 -39,000.00
Jun 30, 2023 -11,000.00
Mar 31, 2023 -10,000.00
Dec 31, 2022 -30,000.00
Sep 30, 2022 30,000.00
Jun 30, 2022 3,000.00
Mar 31, 2022 7,000.00
Dec 31, 2021 2,000.00
Sep 30, 2021 -1,000.00